News

Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a ...
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of the Parse GigaLab™ to scale single cell ...
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study published in the journal Science that utilized Parse’s ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA ...
INTEGRA Biosciences and Parse Biosciences have partnered to automate single cell RNA sequencing (scRNA-seq) on the ASSIST PLUS pipetting robot. This new protocol combines Parse Biosciences ...
SEATTLE, November 21, 2024--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been ...
(BUSINESS WIRE )--Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the. Tuesday, 02 January 2024 12:17 GMT.
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that OMAPiX has been certified as the latest member of its Certified ...